p 88

Iloperidone metabolite Hydroxy Iloperidone is an atypical antipsychotic. It is a metabolite of Iloperidone.

Ziprasidone hydrochloride monohydrate (CP 88059) 是一种联合 5-HT（5-羟色胺）和多巴胺受体拮抗剂，具有抗精神病活性的强效作用。它也是去甲肾上腺素再摄取抑制剂。

Ziprasidone hydrochloride (CP-88059 hydrochloride) 是一种联合 5-HT（5-羟色胺）和多巴胺受体拮抗剂，具有抗精神病活性的强效作用。它也是去甲肾上腺素再摄取抑制剂。

Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) 是有机阴离子转运多肽 1B(OATP1B) 和 OATP1B3抑制剂，IC50分别为 1.5 µM 和 3.27 µM。它也具有口服活性的 HCV NS5A 蛋白抑制剂，多种 HCV 复制子基因型的 EC50范围为 9-146 pM。

Ziprasidone (Geodon) 是一种联合的 5-HT(5-羟色胺)和多巴胺受体拮抗剂，具有强大的抗精神病活性。它是去甲肾上腺素再摄取抑制剂，对大鼠和人的5-HT1A，5-HT2A 和多巴胺 D2 受体有很高的亲和力。

Antibiotic LL-P880y 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T124885，CAS号为 41206-21-7。

Ziprasidone D8 is deuterium labeled Ziprasidone, which is a antagonist of combined 5-HT (serotonin) and dopamine receptor and exhibits potent effects of antipsychotic activity.

GHP-88309 是一种口服有效的广谱抗副黏病毒 (paramyxoviruses) 剂，作用于病毒聚合酶 (viral polymerase)，干扰病毒 RNA 合成，并能够抑制呼吸道合胞病毒 (RSV)、麻疹病毒 (MeV) 和犬瘟热病毒 (CDV)，其EC50范围为0.06-1.2 μM。在小鼠模型中，GHP-88309 显示出抗感染活性。

Bederocin (REP8839) 是一种新型的甲硫酰基tRNA 合成酶(METS)抑制剂，对临床分离的金黄色葡萄球菌、化脓性链球菌和其他临床重要的革兰氏阳性细菌具有有效的抗菌活性。

LL P880 beta is a fungal metabolite.

Daclatasvir (EBP 883) 是一种高度选择性的 HCV NS5A 抑制剂，EC50 为 9-50 pM，适用于细胞培养中的多种 HCV 复制子基因型和 JFH-1 基因型 2a 感染性病毒。

SMP-88480为一类抗体-药物偶联物(Antibody-Drug Conjugates (ADCs))，在小鼠、猴与人血浆中展现出稳定性，并对卵巢癌、胃癌、乳腺癌显示出体内抗肿瘤活性。

Bimosiamose disodium has anti-inflammatory effects[1]. Bimosiamose disodium (TBC-1269Z) is a nonoligosaccharide pan-selectin inhibitor with IC50s of 88 μM, 20 μM, and 86 μM for E-selectin, P-selectin, and L-selectin, respectively.

Bimosiamose has anti-inflammatory effects[1]. Bimosiamose (TBC-1269) is a nonoligosaccharide pan-selectin antagonist with IC50s of 88 μM, 20 μM, and 86 μM for E-selectin, L-selectin, and P-selectin respectively.

P-gp inhibitor 27 (Compound D2) 是一种 P-糖蛋白 (P-gp) 抑制剂，能够降低 P-gp 和 MRP1 的表达，增加 A2780/T 细胞中 Rh123 的积累，并扭转对 Paclitaxel (EC50为 88 nM) 和 Cisplatin 的多药耐药性。

HDAC-IN-88 (Compound HJ-9) 是一种HDAC抑制剂，能够抑制HDAC6、HDAC1、HDAC2、HDAC8和HDAC3，其IC50分别为0.226、1.103、2.308、3.255和3.864 μM。HDAC-IN-88 抑制癌细胞 HepG2、HCT116 和 MV4-11 的增殖，IC50依次为5.47、9.78 和 0.38 μM，并抑制HCT116的迁移，同时在G0/G1期阻滞细胞周期，在MV4-11中引发细胞凋亡 (apoptosis) 和自噬 (autophagy)。HDAC-IN-88 可降低ROS水平和线粒体膜电位，显示出抗疟活性，能够抑制恶性疟原虫P. falciparum3D7，EC50为165 nM。此外，HDAC-IN-88 具备抗血管生成活性。

CC-90005 is a potent, selective and orally active inhibitor of protein kinase C-θ (PKC-θ), with an IC50 of 8 nM. CC-90005 shows selectivity for PKC-θ over PKC-δ (IC50=4440 nM). CC-90005 can inhibit T cell activation by IL-2 expression[1]. CC-90005 shows the exquisite selectivity of CC-90005, with IC50s for all other family members of >3 μM[1].CC-90005 is a moderate inhibitor of both CYP2C9 (IC50=8 μM) and CYP2C19 (IC50=5.9 μM) in human liver microsomes[1].CC-90005 inhibits IL-2 expression in LRS_WBC human PBMCs, with an IC50 of 0.15 μM[1].CC-90005 (1-10 μM; 24 h) inhibits T cell proliferation in PBMCs by 51% at 1 μM and 88% at 3 μM[1]. CC-90005 (3-30 mg/kg; p.o. twice daily for 4 days) significantly reduces the popliteal lymph node (PLN) size in a model of chronic T cell activation[1].CC-90005 (100 mg/kg; a single p.o.) significantly inhibits plasma and spleen IL-2 release by 51 and 54%, respectively[1].CC-90005 exhibits reasonable oral bioavailability (66 and 46%) and Cmax (1.18 and 1.2 μM) following oral administration (10 and 3 mg/kg) in rat and dog, respectively[1].CC-90005 exhibits the mean residence time (0.52 and 2.0 h), CL (69.1 and 20.5 mL/min/kg) and Vss (2.11 and 2.44 L/kg) following intravenous administration (2 and 1 mg/kg) in rat and dog, respectively[1]. [1]. Papa P, et, al. Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005. J Med Chem. 2021 Aug 26;64(16):11886-11903.

Aspulvinone O is a fungal metabolite that has been found in P. variotti and has antioxidant and anticancer activities.1,2 It scavenges 2,2-diphenyl-1-picrylhydrazyl radicals in a cell-free assay (IC50 = 11.6 μM).1 Aspulvinone O inhibits aspartate transaminase 1 (GOT1; Kd = 3.32 μM) and is cytotoxic to PANC-1, AsPC-1, and SW1990 pancreatic cancer cells (IC50s = 20.54-26.8 μM).2 It reduces the oxygen consumption rate (OCR) and induces apoptosis in SW1990 cells. Aspulvinone O (2.5 and 5 mg/kg) reduces tumor growth in an SW1990 mouse xenograft model. |1. Zhang, P., Li, X.-M., Wang, J.-N., et al. New butenolide derivatives from the marine-derived fungus Paecilomyces variotii with DPPH radical scavenging activity. Phytochem. Lett. 11, 85-88 (2015).|2. Sun, W., Luan, S., Qi, C., et al. Aspulvinone O, a natural inhibitor of GOT1 suppresses pancreatic ductal adenocarcinoma cells growth by interfering glutamine metabolism. Cell Commun. Signal. 17(1), 111 (2019).

Saccharocarcin A is an antibiotic originally isolated from S. aerocolonigenes subsp. antibiotica. It is active against M. luteus, S. aureus, E. coli, P. aeruginosa, and C. albicans in a disc assay. Saccharocarcin A inhibits C. trachomatis infection by 88% without inducing cytotoxicity in McCoy cells when used at a concentration of 0.5 μg/ml.

Antileishmanial agent-22 (compound 15b)是一种抗寄生虫和抗菌化合物，展示了对抗利什曼病、疟疾和结核病的活性。该化合物通过抗叶酸途径抑制利什曼原虫（IC50=0.408 μM）。在100 μM浓度时，Antileishmanial agent-22对叶酸和亚叶酸的抑制率分别达到88%和94%。在体内，以48.4 μM/kg/day剂量对伯氏疟原虫展示96.67%的抑制效果；在体外，其IC50值为0.038 μM。Antileishmanial agent-22还能抑制结核分枝杆菌，MIC值为28.44 μM。

Lariciresinol p-coumarate 是一种天然产物，可用于生命科学领域的相关研究。其产品编号为 TN5438，CAS号为 864452-88-0。